跳至主要内容
临床试验/CTRI/2020/04/024777
CTRI/2020/04/024777尚未招募3 期

A Randomized Open Labelled Controlled Clinical Study To Evaluate The Efficacy Of Vamana Karma And Virechana Karma In Pre-Diabetes - VVPD

DR ANJALY PR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age not less than 30 years and not more than 50 years
  • 2.Family H/O type II Diabetes.
  • 3.Fasting blood sugar (glucose) level of: 100mg/dL to 125mg/dL( ADA Criteria)
  • 4.Postprandial blood sugar (glucose)level of: 140mg/dL to 200mg/dL ( ADA Criteria)
  • 5.HbA1c level of: 5.7% - 6.4% ( ADA Criteria)
  • 6.BMI more than 25. (ADA criteria).
  • 7.Subjects who are fit for Vamana & Virechana.

排除标准

  • 1.Subjects who are not fit for Vamana and Virechana.
  • 2.Subjects with known type-2 Diabetes.
  • 3.Subjects already under medication for Diabetes.
  • 4.Subjects who are pregnant and lactating.

研究者

发起方
DR ANJALY PR

相似试验